Daundong, Perlyn .

HRN: 26-05-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/14/2024
10/21/2024
IV
4.5
Q8
T/c Cholangitis
Waiting Final Action 
10/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2024
10/24/2024
PO
500mg
Q8
Hepatic Abscess
Waiting Final Action 
11/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/01/2024
11/08/2024
IV
500mg
Q6
Liver Abscess
Waiting Final Action 
11/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2024
11/15/2024
IV
500mg
Q6h
Hepatic Abscess Metronidazole X 14days Already Completed, Plan To Extend Until 21 Days
Waiting Final Action 
11/16/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/16/2024
11/22/2024
IV
4.5
Q6
Hepatic Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: